A Phase 1, Open-Label, Fixed Sequence Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Debio 1450 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Afabicin (Primary) ; Itraconazole
- Indications Bone and joint infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Debiopharm
- 22 Sep 2017 Status changed from active, no longer recruiting to completed.
- 21 Aug 2017 Planned End Date changed from 25 Oct 2017 to 1 Aug 2017.
- 21 Aug 2017 Planned primary completion date changed from 3 Oct 2017 to 1 Aug 2017.